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Abst rac t
Introduction: The role of long-distance transported (LDT) Ambrosia pollen in inducing new sensitization and affect-
ing sensitization rates in Artemisia-sensitized patients is unclear. 
Aim: The aim of this study was to estimate the degree of cross-sensitization to Ambrosia/Artemisia allergens in 
citizens of Poznan (Western Poland). This area is covered by extensive Artemisia populations but does not currently 
have local Ambrosia populations.
Material and methods: Sera of 119 patients were tested by fluoroenzyme immunoassay (CAP-FEIA system) against 
pollen allergen extracts of Artemisia vulgaris and Ambrosia artemisiifolia, an allergenic component of A. vulgaris 
(nArt v 1), and an allergenic component of A. artemisiifolia (nAmb a 1). Skin prick tests (SPTs, n = 86) were performed 
with pollen allergen extracts of A. vulgaris and A. artemisiifolia. Artemisia and Ambrosia pollen in ambient air was 
collected (1996–2013) by a Hirst type volumetric trap sited at roof level (33 m). 
Results: The SPT showed that the prevalence of sensitization to Ambrosia and Artemisia pollen exceeded 3.5%, and 
10.5%, respectively. The measurements of IgE in blood serum (CAP-FEIA) revealed that among Ambrosia-sensitized 
patients 90.1% (20/22 patients) were concomitantly sensitized to Artemisia. 59.1% (13/22) of these patients reacted 
to nArt v 1, suggesting primary sensitization to Artemisia pollen. Only 2 (9.1%) patients were mono-sensitized to 
Ambrosia pollen extract, but surprisingly not to nAmb a 1. 
Conclusions: The LDT Ambrosia pollen had a negligible effect on the rate of sensitization to Ambrosia allergens in 
Poznan and did not increase the prevalence of sensitization to Artemisia pollen in this region. However, the majority 
of patients showing hypersensitization to Artemisia pollen might also present symptoms during elevated episodes 
of LDT of Ambrosia pollen.
Key words: Amb a 1, Art v 1, immunoglobulin E (IgE), skin prick test, fluorescence-linked immunosorbent assay.
Introduction
Allergens released from Artemisia and Ambrosia 
pollen are an important cause of late-summer allergy 
worldwide [1–3]. Both genera are phylogenetically related 
and belong to the Asteraceae family [4]. Artemisia pol-
len grains contain several types of allergenic proteins, 
e.g. the major allergen Art v 1 (a two-domain glycopro-
tein) and Art v 6 (a pectate lyase) [5, 6]. The major al-
lergen of Ambrosia pollen (Amb a 1) also belongs to the 
pectate lyase protein family and shares 65% sequence 
identity with Art v 6 [5]. Another protein characterized 
from Ambrosia pollen, Amb a 4, is a close homologue 
of Art v 1 [7]. A recent study has shown [8] that these 
proteins play an important role in Artemisia and Ambro-
sia pollen allergy and might be responsible for observed 
cross-sensitization, i.e. the phenomenon of the same IgE 
binding to several different, but structurally similar aller-
gens, such as Art v 1 and Amb 4 [9]. As a result, patients 
sensitized to Artemisia pollen may also show allergy re-
actions when in contact with Ambrosia pollen (and vice 
versa). However, the cross-sensitization should be clearly 
distinguished from co-sensitization – the simultaneous 
presence of different IgEs binding to allergens without 
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common structural features, such as Art v 1 and Amb a 1. 
Although the consequences for patients with co- and 
cross-sensitization are similar, i.e. allergy symptoms to 
both pollen types, the etiology (causative factor) is differ-
ent. This may, in turn, affect the overall cost and efficacy 
of allergy immunotherapy.
Artemisia pollen grains observed in the air of Poland 
(Central Europe) are mainly released by local populations 
of Artemisia species, e.g. A. vulgaris, A. campestris and 
A. absinthium [10]. Artemisia vulgaris is the most widely 
distributed [11] and therefore should be considered as 
the main pollen contributor. The intensity of Artemisia 
pollen seasons recorded in Poland is one of the highest 
in Central and Eastern Europe [12]. In addition, Artemisia 
pollen seasons in Poznan (Western Poland) have started 
earlier and increased in length over the last two decades 
[13]. Artemisia pollen allergens are therefore considered 
to be one of the most common causes of allergic diseas-
es of the upper respiratory tract in Poland, ranking third 
behind Poaceae and Betula pollen allergens [1].
In contrast, Ambrosia artemisiifolia (the most com-
mon ragweed species) is an invasive weed from North 
America, which has currently infested many regions in 
Asia, particularly Eastern China and South Korea [14, 
15], Australia [16], and Europe, especially the Pannonian 
Plain (mainly Hungary and Northern Serbia) as well as 
parts of France, Northern Italy (Po Valley) and Ukraine 
[17]. An expansion of the plant’s distribution into Central 
and Northern Europe (e.g. Germany) has also been ob-
served in recent years [18]. In Poznan, however, Ambrosia 
has only occurred ephemerally and the majority of re-
corded Ambrosia pollen grains are transported from dis-
tant sources, particularly from the Pannonian Plain and 
Ukraine [19–21]. As a result, exposure to Ambrosia pollen 
allergens in Poznan depends highly on meteorological 
conditions facilitating long-distance transport [22]. 
It is interesting to note that in areas where both plant 
species are present, e.g. Northern Italy, an unexpectedly 
high prevalence of concomitant sensitization to these 
airborne allergens has been recorded [8, 23]. In other 
words, the expansion of Ambrosia not only resulted in 
the increase of Ambrosia pollen allergy but also a parallel 
increase in Artemisia pollen sensitization. This phenom-
enon might be especially important in such areas as Po-
land where: (1) a high rate of Artemisia pollen allergy is 
observed; (2) Ambrosia invasion is still in its initial phase 
(mainly limited to the south of the country), and the ma-
jority of ragweed pollen arrived from distant sources. With 
overlapping pollination periods and cross-reacting pollen 
allergens these species may concomitantly affect sensi-
tized patients, hindering appropriate allergy treatment.
Aim
Therefore, the aim of this study is to determine the 
prevalence of Artemisia and Ambrosia pollen allergy and 
to identify the degree of cross-sensitization among citi-
zens of Poznan. In addition, we examined airborne Arte-
misia and Ambrosia pollen concentrations recorded over 
the last 18 years, as exposure is an important factor that 
plays a role in the induction of allergy sensitization. 
Material and methods
Clinical survey
Clinical studies were performed at the Department of 
Dermatology, University of Medical Sciences in Poznan. 
Poznań is the main city of Western Poland (and the fifth 
largest city in Poland) with a population of ~550 000 [24]. 
The examined group included 119 consecutive patients 
(48 males and 71 females), aged 3–66 years. Mean age 
was 22.8 years. Patients were hospitalized, or attended 
our outpatient clinic. They presented various manifesta-
tions of atopy: mostly atopic dermatitis (83 patients – 
70% of examined group), allergic rhinitis and conjuncti-
vitis (29 patients – 24% of examined group) and asthma 
(7 patients – 6% of entire group). All patients were resi-
dents of Poznan and the surrounding area. In all recruit-
ed patients, total and antigen-specific IgE (as IgE) levels 
were measured in serum using fluoroenzyme immunoas-
say (FEIA) (CAP System 100, Phadia) against:
– allergen extract of Artemisia vulgaris pollen,
– allergen extract of Ambrosia artemisiifolia pollen,
– allergenic component Artemisia vulgaris (nArt v 1),
–  allergenic component of Ambrosia artemisiifolia  
(nAmb a 1).
Fluoroenzyme immunoassay (CAP System FEIA – 
Phadia) was used according to the producer’s instruc-
tions. Results were presented as kU/l and interpreted 
according to the age standard (total IgE), or interpreted 
as classes (asIgE) – an antibody level lower than 0.35 kU/l 
was interpreted as “serum antibodies undetectable”.
On the basis of obtained results, the patients were 
divided into 3 subgroups: 
–  Subgroup I. Detectable serum antibodies against Arte-
misia and Ambrosia pollen extracts (Art+/Amb+), cross-
sensitized patients.
–  Subgroup II. No detectable serum antibodies against 
Artemisia pollen extract, but detectable against Ambro-
sia (Art–/Amb+), patients mono-sensitized to Ambrosia 
pollen.
–  Subgroup III. Detectable serum antibodies against Ar-
temisia, but not against Ambrosia pollen extract (Art+/
Amb–), patients mono-sensitized to Artemisia pollen.
Within these three subgroups, the number of pa-
tients with positive reactions to particular allergenic 
components nArt v 1/nAmb a 1 was calculated. Asero 
et al. [8] stated that the major Artemisia pollen allergen 
(Art v 1) can be considered as the best marker of primary 
Artemisia sensitization. On the other hand, due to the 
high cross-reactivity between Amb a 1 and Art v 6, it is 
not possible to distinguish between co- and cross-sensi-
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tization in patients reacting to both major Artemisia and 
Ambrosia pollen allergens (nArt v 1+/nAmb a 1+). As we 
did not include Art v 6 in the FEIA test, all patients show-
ing reactions to Artemisia and Ambrosia pollen extracts/
allergens will be considered, in this study, as cross-sen-
sitized. If sensitization to nArt v 1 was observed (Art+/
Amb+ and nArt v 1+), patients were further classified as 
primary sensitized to Artemisia.
In addition, skin prick tests (SPTs) were performed on 
a total of 86 patients (72% of the 119 patients examined). 
It was not possible to carry out SPTs on the remaining 
33 patients because of significant exacerbations of skin 
inflammatory lesions and constant administration of 
anti-inflammatory and anti-allergic treatment. The SPTs 
were performed using airborne allergen extracts (Allergo-
pharma GmbH & Co. KG, Reinbek, Germany): Artemisia 
vulgaris and Ambrosia artemisiifolia. Each allergen con-
centration in a tested substance was expressed as bio-
logical units (BE/ml or SBE/ml) and/or PNU.
The SPTs were applied to the skin on the inner part of 
the forearm, approximately 5 cm from the wrist and 3–5 
cm from popliteal fossa. The SPTs were examined 20 min 
after application and the results were presented as the 
mean diameter of the wheal and erythema, but also on 
a “plus” scale by comparing the diameters of allergen 
wheal and control wheal (both positive and negative con-
trol). In addition, a doubtful result was defined as an al-
lergen wheal with mean diameter equal to or larger than 
the half of the mean diameter of a histamine wheal [25].
Pollen monitoring
Artemisia and Ambrosia pollen grains in ambient air 
were collected (1996–2013) by a volumetric trap of the 
Hirst design [26] sited at roof level (33 m) approximately 
8 km from Poznan city centre (52˚24'N 16˚53'E). The pol-
len counting methods used in Poznan during the years 
studied have previously been described in detail [27]. 
Daily averages of airborne Artemisia and Ambrosia pollen 
counts were converted to concentrations and expressed 
as particles per cubic metre of air (P/m3) [28].
The number of days with daily mean Artemisia and 
Ambrosia pollen concentrations ≥ 30 P/m3 was extracted 
from the pollen database. The threshold value (≥ 30 P/
m3) was chosen based on the atmospheric concentra-
tions of Artemisia and Ambrosia pollen often reported to 
evoke allergic symptoms (De Weger et al. [29] and refer-
ences therein). Next, the probability risk (p) of recording 
at least 1, 3, 5, 7 and 10 days with an elevated daily mean 
Artemisia and/or Ambrosia pollen level (≥ 30 P/m3) dur-
ing every decade from the beginning of July to the end 
of September was calculated. The following descriptors 
of probability were applied (adapted from [30]: very low 
(0.0 ≤ p ≤ 0.25), low (0.25 < p ≤ 0.50), medium (0.5 < p ≤ 
0.75), high (0.75 < p ≤ 0.90), very high (0.90 < p ≤ 1.00).
Results
Clinical survey
FEIA: Out of all recruited patients (n = 119), positive 
results for Artemisia and/or Ambrosia allergen extracts 
were obtained in 29 patients (29/119 – 24.4%) (Table 1). 
Twenty-two (18.5%) patients reacted to Ambrosia pol-
len extract (Subgroups I and II): 
–  The majority of these patients (20/22 – 90.1%) were 
also sensitized to Artemisia pollen extract, and 59.1% 
(13/22) of them reacted to nArt v 1, suggesting primary 
sensitization to Artemisia pollen. 
–  Eight patients (8/22 – 36.4%) did not react to nAmb 
a 1 and nArt v 1; they could therefore be sensitized to 
other (minor) Ambrosia/Artemisia pollen allergens. 
Six of them (Subgroup I; Art+/Amb+) were potentially 
cross-sensitized, and the remaining 2 (Subgroup II, 
Art–/Amb+) were mono-sensitized to Ambrosia pollen, 
but surprisingly not to the major Ambrosia pollen al-
lergen – nAmb a 1. 
–  Four patients (4/22 – 18.2%) reacted to the major Am-
brosia pollen allergen – nAmb a 1, but only 1 patient 
did not show concomitant reaction to nArt v 1. As this 
patient also reacted to Artemisia pollen extract (Art+), 
Table 1. Results of FEIA grouped according to hypersensitivity to Ambrosia and/or Artemisia pollen extract detected in 
119 examined patients
Clinical test Ambrosia and Artemisia allergen extracts (subgroups) Sum
Subgroup I 
Art+/Amb+ (number  
of patients; %)
Subgroup II 
Art–/Amb+ (number 
of patients; %)
Subgroup III
Art+/Amb– (number 
of patients; %)
20/119 (16.8%) 2/119 (1.7%) 7/119 (5.9%) 29/119 (24.0%)
A
lle
rg
en
ic
 
co
m
po
ne
nt
s
nAmb a 1 (+)/nArt v 1 (+) 3 (15%) 0 0 3 (10.4%)
nAmb a 1 (+)/nArt v 1 (–) 1 (5%) 0 0 1 (3.4%)
nAmb a 1 (–)/nArt v 1 (+) 10 (50%) 0 4 (57%) 14 (48.3%)
nAmb a 1 (–)/nArt v 1 (–) 6 (30%) 2 (100%) 3 (43%) 11 (37.9%)
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there is a high chance that the reaction to nAmb a 1 
resulted from the cross-sensitivity to Art v 6.
Twenty-seven patients were sensitized to Artemisia 
pollen extract (20 from Subgroup I and 7 from Subgroup 
III). 74.1% (20/27) of them reacted to Ambrosia pollen 
extract. A total of 63% (17/27) showed reactions to the 
major Artemisia pollen allergen nArt v 1. 
SPT: Of the 86 atopic patients examined, a total of 
16 patients presented either positive (9/86 – 10.5%) or 
doubtful (7/86 – 8%) results for Artemisia allergen ex-
tract (Figure 1). With respect to the Ambrosia allergen 
extract, 3 patients exhibited positive (3/86 – 3.5%) and 
9 patients doubtful (9/86 – 10.5%) SPTs. Simultaneously 
positive and/or doubtful SPT results for both allergens 
were obtained in 9 out of 86 patients (10.5%). 
Aerobiological data
During the examined period (July–September) the 
highest probability of recording at least 1 day with an 
elevated Artemisia pollen level (≥ 30 Artemisia P/m3 daily 
average) was observed in the 1st and 2nd 10-day period in 
August (p = 0.89) (Figure 2 A). During the 1st 10-day pe-
riod the probability was also high for ≥ 3 days (p = 0.83) 
and medium for ≥ 5 and ≥ 7 days with ≥ 30 Artemisia 
P/m3 (p = 0.72 and p = 0.61, respectively). In relation to 
Ambrosia pollen, the probability of exceeding the thresh-
old value (≥ 30 Ambrosia P/m3 daily average) at least 
once during a 10-day period was the highest in the 3rd 
10-day period in August and the 1st 10-day period in Sep-
tember (p = 0.28 and p = 0.22, respectively) (Figure 2 B). 
In general, the probability of recording elevated daily 
mean Ambrosia pollen levels during selected 10-day 
periods was very low or low (never exceeding ≥ 0.30). 
When both taxa were considered together (Figure 2 C) 
the most distinct differences were observed in the 3rd 10-
day period in August, when the probability of recording 
at least one day with mean daily Artemisia or Ambrosia 
pollen levels ≥ 30 P/m3 increased to 0.39. However, the 
probability of simultaneously observing elevated daily 
average concentrations of pollen (≥ 30 P/m3) from both 
pollen taxa in the same 10-day period was very low (e.g. 
p = 0.19 in the 3rd 10-day period of August) (Figure 2 D). 
Discussion
The prevalence of pollen allergy to particular plant 
species is closely related to the geographical location, and 
more specifically to the intensity of pollen exposure in 
that area. In Poland, where Artemisia pollen is considered 
to be an important aeroallergen, the prevalence to Arte-
misia pollen allergens is over 20% and one of the highest 
in Europe [1]. In our study, depending on tests used, the 
prevalence varies from 10.5% (positive reaction in SPT), 
to 15.1% (positive reaction to Art v 1), and 22.7% (positive 
reaction to Artemisia pollen extract). It is worth noting 
that among patients sensitized to Artemisia pollen ex-
tract (FEIA), 63% reacted positively to the allergenic com-
ponent nArt v1 (the major Artemisia pollen allergen). The 
remaining Artemisia-hypersensitive patients presumably 
reacted to other Artemisia pollen allergens. For instance, 
according to Gadermaier et al. [31] Art v 3 can be consid-
ered as a new major Artemisia pollen allergen, with the 
Figure 1. Comparison of the annual sum of airborne Artemisia (A) and Ambrosia (B) pollen between 1996–2004 and 
2005–2013, and SPT values against Ambrosia and Artemisia pollen in Poznan. Data collection: *2002–2004 from Stach 
et al. (2005); **2010–2012 from this study
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prevalence of reactivity among Artemisia pollen-sensitized 
individuals reaching 85%. The comparison of SPT results 
obtained in this study with results obtained in a previous 
analysis conducted during 2002–2004 [32] shows that the 
rate of sensitization to Artemisia pollen has not markedly 
changed (from 11.6% to 10.5%). Although the pollen level 
of Artemisia is gradually decreasing in Poznan (likely due 
to drier summers and reduction of suitable habitats) [13], 
Artemisia still represents a major source of allergenic sen-
sitization in atopic patients, with stable prevalence over 
the last decade. These results are in contrast with North-
ern Italy, where the prevalence of Artemisia sensitivity has 
increased dramatically during recent decades in parallel 
with the spread of Ambrosia [33]. 
For Ambrosia, the highest rate of allergy is observed 
in countries that are significantly infested by this plant, 
such as Hungary and France [1]. On the other hand, there 
is almost no sensitization to Ambrosia pollen allergens in 
Scandinavia (a region with negligible local sources). The 
estimated prevalence of sensitization to Ambrosia pollen 
in Poznan (3.5%) is similar to that observed in Scandina-
via (i.e. 2.3% in Finland), and lower than in neighbouring 
countries, e.g. 14.4% in Germany [1] and around 20% in 
Czech Republic [34]. It is also lower than the rate of sen-
sitization to Ambrosia pollen allergens observed in other 
Polish cities, e.g. 10.8% in Lodz (Central Poland) [1], and 
almost 50% of patients reacted to Ambrosia pollen aller-
gens in Krakow (Southern Poland) [35]. These two cities 
are located further south than Poznan, and as such are 
nearer to the northern distribution range of Ambrosia in 
Europe [17]. Moreover, in Southern Poland Ambrosia ar-
temisiifolia occurs in several well-established populations 
(> 1000 individuals), becoming a distinct local source of 
Ambrosia pollen [36].
It should, however, be noted that exposure to pollen 
is not only related to the plant’s distribution area but may 
also depend on the ability of pollen to be transported 
over long distances. Episodes of long-distance transport 
(LDT) of Ambrosia pollen from infested to “ragweed-free” 
areas, such as Poznan, have been detected over the last 
Figure 2. Probability of recording a certain a number of days with elevated mean daily Artemisia (A), Ambrosia (B), Ar-
temisia OR Ambrosia (C), and Artemisia AND Ambrosia (D) pollen concentrations (≥ 30 P/m3) in the air of Poznan during 
every 10-day period from the beginning of July to the end of Septemwber
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decades [19–21]. A recent study [37] also revealed that 
these pollen grains maintain their allergic potency during 
the atmospheric transport and therefore are equipped 
to induce allergic reactions in sensitized patients. How-
ever, it is still unclear whether this may affect the overall 
prevalence of Ambrosia pollen allergy. For instance, Ce-
cchi et al. [38] observed that the prevalence of Ambro-
sia sensitization remains low (< 10%) in Northern Italy, 
where people are only exposed to LDT Ambrosia pollen. 
The same situation can be observed in Poznan. We found 
that the probability of recording high atmospheric con-
centrations of Ambrosia pollen in Poznan is low or very 
low (p < 0.30). In addition, as previous studies revealed 
[20, 22], episodes of LDT of pollen are short (lasting 1–2 
days) and usually not very intense. It therefore seems 
that LDT episodes are too intermittent to markedly influ-
ence the prevalence of allergy. On the other hand, the 
distribution range area of Ambrosia in Europe is chang-
ing, mainly expanding into northerly areas [39]. We may 
therefore expect that the frequency and magnitude of 
LDT episodes will increase in areas such as Poznan as 
a product of reduced distance to the pollen source. As 
a consequence, it may cause the prevalence of sensiti-
zation to Ambrosia pollen allergy to increase, as seen in 
Germany [1].
Due to the cross-sensitization between Artemisia and 
Ambrosia pollen allergens, the expansion of ragweed 
may be particularly important for people already sensi-
tized to Artemisia. In our study, almost 75% of patients 
sensitized to Artemisia pollen extract showed positive re-
actions to Ambrosia pollen extract. In addition, possible 
cross-sensitization was observed in 55% of patients with 
positive reactions to Artemisia and Ambrosia pollen ex-
tract (Subgroup I). The majority of these patients were 
primarily sensitized to Artemisia. As a result, we should 
expect that over half of patients showing hypersensitisa-
tion to Artemisia pollen might also present symptoms 
during elevated episodes of LDT of Ambrosia pollen. This 
is most likely to occur at the end of August and beginning 
of September, i.e. the period with the highest probability 
of recording high concentrations of Ambrosia pollen in 
the air. Although the risk is still low, this should be taken 
into account when investigating unusual occurrences of 
allergy symptoms in sensitized patients during the late 
Artemisia pollen season. 
Six of the patients (27.3%) belong to Subgroup I (Art+/
Amb+), suggesting cross-sensitization, likely to pan-aller-
gens such as profilins (e.g. Amb a 8 and Art a 4) or calcium-
binding proteins (e.g. Art v 5, Amb a 9 and Amb a 10) [40]. 
In contrast to the high prevalence of cross-sensitization 
among investigated patients with Artemisia and Ambrosia 
pollen allergy, the frequency of possible co-sensitization 
was rather low (15%). In addition, as we did not investigate 
the reactivity to Art v 6 (which is a homologue of Amb a 1), 
we cannot exclude the possibility that these patients were 
in fact cross-sensitized. The low prevalence of co-sensiti-
zation observed in Poznan concurs with the findings from 
other European studies. For instance, in Switzerland, the 
observed sensitization to Ambrosia was in most cases 
a consequence of a primary sensitization to Artemisia 
[41], whilst no co-sensitized patients have been found in 
Northern Italy [8].
Conclusions
Western Poland is currently a ragweed free area, 
without local plant populations, and the majority of 
pollen grains recorded in Poznan are transported from 
very far away. However, in recent decades the distance 
from the nearest Ambrosia sources has been gradu-
ally decreasing. Ambrosia has infested areas in North-
ern Europe; it has been observed in Eastern Germany 
and Southern Poland. The “ragweed pollen noose” is 
slowly tightening… how this situation will affect the al-
lergic population of Poznan is still uncertain. However, 
it seems that nowadays, Ambrosia pollen does not pose 
a high allergenic risk in Poznan. The probability of record-
ing elevated mean daily Ambrosia pollen levels is still low 
and limited to a 20-day period (in late August and early 
September). In addition, the chances of observing high 
concentrations of Artemisia and Ambrosia pollen in the 
air at the same time are even lower, which should be 
helpful information for physicians choosing appropriate 
allergy immunotherapy. Finally, the prevalence of Ambro-
sia pollen allergy is very low, and the co-sensitization to 
both investigated species is a rather rare phenomenon. 
This positive information should not, however, lull our 
sense of security. Ambrosia produces one of the most 
potent aeroallergens and its distribution range is gradu-
ally expanding; it surely requires the highest attention. 
Acknowledgments
Clinical studies were performed at the Department of 
Dermatology, University of Medical Sciences in Poznan.
This work was funded by Polish National Science 
Centre grants No. NN404015439 and No. 2011/03/D/
NZ7/06224. The results presented here relate to Euro-
pean COST Action FA1203 “Sustainable management of 
Ambrosia artemisiifolia in Europe (SMARTER)”. We thank 
A. Szymańska and Ł. Kostecki for help with data collec-
tion and technical assistance.
Conflict of interest 
The authors declare no conflict of interest.
References
1. Burbach GJ, Heinzerling LM, Edenharter G, et al. GA2LEN 
skin test study II: clinical relevance of inhalant allergen sen-
sitizations in Europe. Allergy 2009; 64: 1507-15.
Advances in Dermatology and Allergology 1, February / 2018 
Cross-sensitization to Artemisia and Ambrosia pollen allergens in an area located outside of the current distribution 
range of Ambrosia
89
2. Oswalt ML, Marshall GD. Ragweed as an example of world-
wide allergen expansion. Allergy Asthma Clin Immunol 
2008; 4: 130-5.
3. Tang R, Sun JL, Yin J, et al. Artemisia allergy research in Chi-
na. Biomed Res Intern 2015; 2015: 179426.
4. Jäger S. Plant taxonomy and nomenclature. Postep Derm 
Alergol 2003; 20: 218-26.
5. Jahn-Schmid B, Hauser M, Wopfner N, et al. Humoral and 
cellular cross-reactivity between Amb a 1, the major rag-
weed pollen allergen, and its Mugwort homolog Art v 6. 
J Immunol 2012; 188: 1559-67.
6. Gadermaier G, Hauser M, Ferreira F. Allergens of weed pol-
len: an overview on recombinant and natural molecules. 
Methods 2014; 66: 55-66.
7. Leonard R, Wopfner N, Pabst M, et al. A new allergen from 
ragweed (Ambrosia artemisiifolia) with homology to Art v 1 
from mugwort. J Biol Chem 2010; 285: 27192-200.
8. Asero R, Bellotto E, Ghiani A, et al. Concomitant sensitiza-
tion to ragweed and mugwort pollen: who is who in clinical 
allergy? Ann Allergy Asthma Immunol 2014; 113: 307-13.
9. Migueres M, Davila I, Frati F, et al. Types of sensitization to 
aeroallergens: definitions, prevalences and impact on the 
diagnosis and treatment of allergic respiratory disease. Clin 
Transl Allergy 2014; 4: 16.
10. Bogawski P, Grewling Ł, Frątczak A. Flowering phenology 
and potential pollen emission of three Artemisia species in 
relation to airborne pollen data in Poznań (Western Poland). 
Aerobiologia 2016; 32: 265-76.
11. Zając A, Zając M. Atlas rozmieszczenia roślin naczyniowych 
w Polsce. Distribution atlas of vascular plants in Poland. In-
stytut Botaniki Uniwersytetu Jagiellońskiego Kraków 2001.
12. Grewling Ł, Šikoparija B, Skjøth CA, et al. Variation in Arte-
misia pollen seasons in Central and Eastern Europe. Agric 
For Meteorol 2012; 160: 48-59.
13. Bogawski P, Grewling Ł, Nowak M, et al. Trends in atmo-
spheric concentrations of weed pollen in the context of 
recent climate warming in Poznań (Western Poland). Int 
J Biometeorol 2014; 58: 1759-68.
14. Oh JW, Lee HB, Kang IJ, et al. The revised edition of Korean 
calendar for allergenic pollens. Allergy Asthma Immunol Res 
2012; 4: 5-11.
15. Chen H, Chen L, Albright TP. Developing habitat-suitability 
maps of invasive  ragweed (Ambrosia artemisiifolia.L) in 
China using GIS and statistical methods In Lai PC, Mak ASH, 
(Eds). GIS for Health and the Environment Development in 
the Asia-Pacific Region: Springer 2007.
16. Bass DJ, Delpech V, Beard J, et al. Ragweed in Australia. Aero-
biologia 2000; 16: 107-11.
17. Smith M, Cecchi L, Skjøth CA, et al. Common ragweed: 
a threat to environmental health in Europe. Environ Int 2013; 
61: 115-26.
18. Cunze S, Leiblein MC, Tackenberg O. Range expansion of 
Ambrosia artemisiifolia in Europe is promoted by climate 
change. ISRN Ecology 2013; 2013: 610126.
19. Smith M, Skjøth CA, Myszkowska D, et al. Long-range trans-
port of Ambrosia pollen to Poland. Agric For Meteorol 2008; 
148: 1402-11.
20. Stach A, Smith M, Skjøth CA, et al. Examining Ambrosia pol-
len episodes at Poznan (Poland) using back-trajectory analy-
sis. Int J Biometeorol 2007; 51: 275-86.
21. Kasprzyk I, Myszkowska D, Grewling Ł, et al. The occurrence 
of Ambrosia pollen in Rzeszów, Kraków and Poznań, Poland: 
investigation of trends and possible transport of Ambrosia 
pollen from Ukraine. Int J Biometeorol 2011; 55: 633-44.
22. Šikoparija B, Skjøth CA, Alm Kübler K, et al. A mechanism for 
long distance transport of Ambrosia pollen from the Panno-
nian plain. Agric For Meteorol 2013; 180: 112-7.
23. Asero R, Wopfner N, Gruber P, et al. Artemisia and Ambrosia 
hypersensitivity: co-sensitization or co-recognition? Clin Exp 
Allergy 2006; 36: 658-65.
24. CSO. Area and population in the territorial profile in 2013. 
Statistical Information and Elaborations. Warsaw: Methodol-
ogy, Standards and Registers Department. Central Statistical 
Office 2013 2013.
25. Kruszewski J, Silny W, Mazurek H, et al. Testy skórne. Stan-
dardy w alergologii. Część I. The UCB Institute of Allergy 
Belgium 2003; 9-29.
26. Hirst JM. An automatic volumetric spore trap. Ann Appl Biol 
1952; 39: 257-65.
27. Grewling Ł, Jackowiak B, Nowak M, et al. Variations and 
trends of birch pollen seasons during 15 years (1996-2010) in 
relation to weather conditions in Poznań (Western Poland). 
Grana 2012; 51: 280-92.
28. Comtois P. Statistical analysis of aerobiological data. In: 
Methods in Aerobiology. Mandrioli P, Comtois P, Levizzani V 
(eds). Pitagora Editrice, Bologna 1998.
29. De Weger LA, Bergmann KC, Rantio Lehtimäki A, et al. Im-
pact of pollen. In: Allergenic Pollen: a Review of the Produc-
tion, Release, Distribution and Health Impacts. Sofiev M, 
Bergmann KC (eds). Springer, Dordrecht 2013.
30. Garcia ML. Design and Evaluation of Physical Protection Sys-
tems. 2 edn. Butterworth Heinemann 2007.
31. Gadermaier G, Wopfner N, Wallner M, et al. Array-based 
profiling of ragweed and mugwort pollen allergens. Allergy 
2008; 63: 1543-9.
32. Stach A, García-Mozo H, Prieto-Baena JC, et al. Prevalence of 
Artemisia species pollinosis in Western Poland: impact of cli-
mate change on aerobiological trends, 1995-2004. J Investig 
Allergol Clin Immunol 2007; 17: 39-47.
33. Asero R. Is the strange case of mugwort sensitivity in rag-
weedallergic subjects coming eventually to a solution? Eur 
Ann Allergy Clin Immunol 2011; 43: 67-68.
34. Rybníček O, Novotná B, Rybníckova E, et al. Ragweed in the 
Czech Republic. Aerobiologia 2000; 16: 287-90.
35. Obtulowicz K, Szczepanek K, Myszkowska D. Ambrosia pol-
len grains in aeroplankton of Krakow and their role in pol-
len allergy of this region. In: Pollens and Pollinosis: Current 
Problems: Spiewak R (ed). Institute of Agricultural Medicine, 
Lublin (Poland) 1995; 56.
36. Tokarska-Guzik B, Bzdęga K, Koszela K, et al. Allergenic inva-
sive plant Ambrosia artemisiifolia L. in Poland: threat and se-
lected aspects of biology. Biodiv Res Conserv 2011; 21: 39-48.
37. Grewling Ł, Nowak M, Jenerowicz D, et al. Atmospheric 
concentrations of ragweed pollen and Amb a 1 recorded in 
Poznań (Poland). Allergy 2013; 68 (Suppl. 97): 637-707.
38. Cecchi L, Testi S, Campi P, et al. Long-distance transport of 
ragweed pollen does not induce new sensitizations in the 
short term. Aerobiologia 2010; 26: 351-2.
39. Storkey J, Stratonovitch P, Chapman DS, et al. A process-
based approach to predicting the effect of climate change 
on the distribution of an invasive allergenic plant in Europe. 
PLoS One 2014; 12: e88156.
40. Hauser M, Roulias A, Ferreira F, et al. Panallergens and their 
impact on the allergic patient. Allergy Asthma Clin Immunol 
2010; 6: 1.
41. Ackermann-Liebrich A, Schindler C, Frei P, et al. Sensitisation 
to Ambrosia in Switzerland: a public health threat in waiting. 
Swiss Med Wkly 2009; 139: 70-5.
